chr10:123239371:> Detail (hg19) (FGFR2)

Information

Genome

Assembly Position
hg19 chr10:123,239,371-123,357,917
hg38 chr10:121,479,857-121,598,403 

HGVS

Type Transcript Protein
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

Frequency

[No Data.]

Prediction

[No Data.]

ClinVar

Clinical Significance
Review star [No Data.]
Show details
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
Disease Drug EL ET ED CS VO TR Pubmed Links
endometrial cancer Ponatinib D Predictive Supports Sensitivity/Response Somatic 3 26574622 Detail
cholangiocarcinoma Infigratinib C Predictive Supports Sensitivity/Response Somatic 2 27870574 Detail
DisGeNET
[No Data.]
Annotation

Annotations

DescrptionSourceLinks
Preclinical study in endometrial cancer cell lines (MFE-296, AN3CA, MFE-280 and Ishikawa). In cell p... CIViC Evidence Detail
Phase 1 study of FGFR-inhibitor BGJ398 in advanced cancer with FGFR-aberrations. Among three patient... CIViC Evidence Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
-
Genome
hg19
Position
chr10:123,239,371-123,357,917
Variant Type
snv
Variant (CIViC) (CIViC Variant)
MUTATION
Transcript 1 (CIViC Variant)
ENST00000457416.2
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/511
Genome browser